Cancer
MONDO:0004992A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.
Also known as: CA, cancer, cell type cancer, malignancy, malignant growth, malignant neoplasm, malignant neoplasm (disease), malignant neoplastic disease
28041 clinical trials for this condition and its sub-types, 2537 tagged with Cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Cancer
-
Carcinoma 224 trials · 14,728 incl. sub-types
49 sub-types
- Adenocarcinoma 184 trials · 5,246 incl. sub-types Sub-types →
- Digestive system carcinoma 25 trials · 4,880 incl. sub-types Sub-types →
- Lung carcinoma 137 trials · 3,320 incl. sub-types Sub-types →
- Breast carcinoma 665 trials · 2,688 incl. sub-types Sub-types →
- Squamous cell carcinoma 177 trials · 1,768 incl. sub-types Sub-types →
- Head and neck carcinoma 73 trials · 1,415 incl. sub-types Sub-types →
- Prostate carcinoma 394 trials · 1,321 incl. sub-types Sub-types →
- Renal carcinoma 85 trials · 764 incl. sub-types Sub-types →
- Neuroendocrine carcinoma 106 trials · 744 incl. sub-types Sub-types →
- Transitional cell carcinoma 249 trials · 721 incl. sub-types Sub-types →
- Urinary bladder carcinoma 392 trials · 669 incl. sub-types Sub-types →
- Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types Sub-types →
- Uterine carcinoma 3 trials · 611 incl. sub-types Sub-types →
- Invasive carcinoma 4 trials · 604 incl. sub-types Sub-types →
- Peritoneal carcinoma 16 trials · 389 incl. sub-types Sub-types →
- In situ carcinoma 25 trials · 318 incl. sub-types Sub-types →
- Skin carcinoma 34 trials · 281 incl. sub-types Sub-types →
- Thyroid gland carcinoma 41 trials · 237 incl. sub-types Sub-types →
- Fallopian tube carcinoma 126 trials · 182 incl. sub-types Sub-types →
- Secondary carcinoma 1 trial · 169 incl. sub-types Sub-types →
- Bone carcinoma 0 trials · 131 incl. sub-types Sub-types →
- Basal cell carcinoma 111 trials · 120 incl. sub-types Sub-types →
- Laryngeal carcinoma 56 trials · 114 incl. sub-types Sub-types →
- Papillary carcinoma 8 trials · 112 incl. sub-types Sub-types →
- Large cell carcinoma 2 trials · 87 incl. sub-types Sub-types →
- Undifferentiated carcinoma 6 trials · 80 incl. sub-types Sub-types →
- Mucin-producing carcinoma 0 trials · 58 incl. sub-types Sub-types →
- Retroperitoneum carcinoma 0 trials · 52 incl. sub-types Sub-types →
- Vulvar carcinoma 24 trials · 45 incl. sub-types Sub-types →
- Thymic carcinoma 41 trials · 44 incl. sub-types Sub-types →
- Penile carcinoma 9 trials · 35 incl. sub-types Sub-types →
- Sarcomatoid carcinoma 1 trial · 26 incl. sub-types Sub-types →
- Vaginal carcinoma 12 trials · 22 incl. sub-types Sub-types →
- Carcinoma of urethra 2 trials · 21 incl. sub-types Sub-types →
- Ureter carcinoma 1 trial · 19 incl. sub-types Sub-types →
- Choroid plexus carcinoma 11 trials Sub-types →
- Basaloid carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Cribriform carcinoma 1 trial · 4 incl. sub-types Sub-types →
- Combined carcinoid and adenocarcinoma 0 trials · 2 incl. sub-types Sub-types →
- Malignant myoepithelioma 2 trials Sub-types →
- Carcinoma ex pleomorphic adenoma 1 trial Sub-types →
- Scrotal carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Trachea carcinoma 1 trial Sub-types →
- Krebs 2 carcinoma 0 trials
- Comedocarcinoma 0 trials
- Epithelial-myoepithelial carcinoma 0 trials Sub-types →
- Glycogen-rich carcinoma 0 trials Sub-types →
- Lipid-rich carcinoma 0 trials Sub-types →
- Lymph node carcinoma 0 trials
-
Thoracic cancer 61 trials · 8,237 incl. sub-types
8 sub-types
- Breast cancer 3,492 trials · 4,513 incl. sub-types Sub-types →
- Lung cancer 1,207 trials · 3,941 incl. sub-types Sub-types →
- Mediastinal cancer 10 trials · 191 incl. sub-types Sub-types →
- Pleural cancer 9 trials · 83 incl. sub-types Sub-types →
- Heart cancer 2 trials · 4 incl. sub-types Sub-types →
- Malignant neoplasm of chest wall 1 trial Sub-types →
- Askin tumor 0 trials
- Sternum cancer 0 trials Sub-types →
-
Digestive system cancer 267 trials · 7,058 incl. sub-types
15 sub-types
- Digestive system carcinoma 25 trials · 4,880 incl. sub-types Sub-types →
- Intestinal cancer 25 trials · 2,787 incl. sub-types Sub-types →
- Liver cancer 254 trials · 1,701 incl. sub-types Sub-types →
- Malignant pancreatic neoplasm 900 trials · 1,446 incl. sub-types Sub-types →
- Gastric cancer 724 trials · 1,034 incl. sub-types Sub-types →
- Esophageal cancer 408 trials · 788 incl. sub-types Sub-types →
- Pharynx cancer 10 trials · 495 incl. sub-types Sub-types →
- Oral cavity cancer 42 trials · 288 incl. sub-types Sub-types →
- Gastroesophageal cancer 157 trials
- Gallbladder cancer 73 trials · 106 incl. sub-types Sub-types →
- Gastrointestinal lymphoma 0 trials · 7 incl. sub-types Sub-types →
- Jaw cancer 1 trial · 5 incl. sub-types Sub-types →
- Digestive system melanoma 0 trials · 2 incl. sub-types Sub-types →
- Malignant tumor of floor of mouth 0 trials · 2 incl. sub-types Sub-types →
- Spleen cancer 0 trials · 2 incl. sub-types Sub-types →
-
Respiratory system cancer 6 trials · 4,516 incl. sub-types
9 sub-types
- Lung cancer 1,207 trials · 3,941 incl. sub-types Sub-types →
- Pharynx cancer 10 trials · 495 incl. sub-types Sub-types →
- Larynx cancer 41 trials · 125 incl. sub-types Sub-types →
- Pleural cancer 9 trials · 83 incl. sub-types Sub-types →
- Bronchus cancer 3 trials · 26 incl. sub-types Sub-types →
- Paranasal sinus cancer 4 trials · 24 incl. sub-types Sub-types →
- Nasal cavity cancer 5 trials · 14 incl. sub-types Sub-types →
- SMARCA4-deficient sarcoma of thorax 8 trials
- Tracheal cancer 0 trials · 1 incl. sub-types Sub-types →
-
Reproductive system cancer 4 trials · 4,381 incl. sub-types
8 sub-types
- Male reproductive organ cancer 22 trials · 2,347 incl. sub-types Sub-types →
- Female reproductive organ cancer 245 trials · 2,253 incl. sub-types Sub-types →
- Pituitary cancer 2 trials · 4 incl. sub-types Sub-types →
- Malignant Leydig cell tumor 0 trials · 1 incl. sub-types Sub-types →
- Buschke Lowenstein tumor 0 trials Sub-types →
- Gonadoblastoma 0 trials Sub-types →
- Malignant Sertoli cell tumor 0 trials
- Prepuce cancer 0 trials
-
Immune system cancer 0 trials · 3,121 incl. sub-types
25 sub-types
- Bone marrow cancer 2 trials · 1,631 incl. sub-types Sub-types →
- Plasma cell myeloma 1,105 trials · 1,128 incl. sub-types Sub-types →
- Thymus cancer 10 trials · 225 incl. sub-types Sub-types →
- Primary central nervous system lymphoma 92 trials · 103 incl. sub-types Sub-types →
- Lymphatic system cancer 4 trials · 69 incl. sub-types Sub-types →
- Dendritic cell sarcoma 0 trials · 53 incl. sub-types Sub-types →
- B-cell childhood acute lymphoblastic leukemia 37 trials
- T-cell childhood acute lymphocytic leukemia 10 trials
- Waldeyer's ring cancer 0 trials · 8 incl. sub-types Sub-types →
- Subcutaneous panniculitis-like T-cell lymphoma 8 trials
- Primary vitreoretinal large b-cell lymphoma 3 trials
- Indolent primary cutaneous B-cell lymphoma 1 trial · 2 incl. sub-types Sub-types →
- Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood 2 trials
- Breast diffuse large B-cell lymphoma 1 trial
- Colon Burkitt lymphoma 0 trials
- Colorectal diffuse large B-cell lymphoma 0 trials
- Gastric mantle cell lymphoma 0 trials
- Liver diffuse large B-cell lymphoma 0 trials
- Mast cell sarcoma 0 trials
- Primary pulmonary diffuse large B-cell lymphoma 0 trials
- Small intestinal Burkitt lymphoma 0 trials
- Small intestinal diffuse large B-cell lymphoma 0 trials
- Small intestinal enteropathy-associated T-cell lymphoma 0 trials
- Solitary plasmacytoma of chest wall 0 trials
- Thyroid gland diffuse large B-cell lymphoma 0 trials
-
Malignant endocrine neoplasm 17 trials · 2,925 incl. sub-types
16 sub-types
- Liver cancer 254 trials · 1,701 incl. sub-types Sub-types →
- Neuroendocrine carcinoma 106 trials · 744 incl. sub-types Sub-types →
- Thyroid cancer 166 trials · 328 incl. sub-types Sub-types →
- Thymus cancer 10 trials · 225 incl. sub-types Sub-types →
- Adrenal gland cancer 16 trials · 62 incl. sub-types Sub-types →
- Pineal gland cancer 0 trials · 19 incl. sub-types Sub-types →
- Malignant tumor of parathyroid gland 2 trials · 6 incl. sub-types Sub-types →
- Maligant granulosa cell tumor of ovary 5 trials
- Pituitary cancer 2 trials · 4 incl. sub-types Sub-types →
- Ovarian neuroendocrine neoplasm 0 trials · 2 incl. sub-types Sub-types →
- High-grade neuroendocrine carcinoma of the corpus uteri 0 trials
- Low-grade neuroendocrine tumor of the corpus uteri 0 trials
- Malignant carotid body paraganglioma 0 trials
- Malignant jugulotympanic paraganglioma 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
-
Head and neck cancer 637 trials · 2,004 incl. sub-types
16 sub-types
- Head and neck carcinoma 73 trials · 1,415 incl. sub-types Sub-types →
- Malignant tumor of neck 14 trials · 505 incl. sub-types Sub-types →
- Ocular cancer 10 trials · 168 incl. sub-types Sub-types →
- Salivary gland cancer 62 trials · 81 incl. sub-types Sub-types →
- Skull cancer 0 trials · 38 incl. sub-types Sub-types →
- Tongue cancer 26 trials · 35 incl. sub-types Sub-types →
- Lip cancer 12 trials · 15 incl. sub-types Sub-types →
- Nasal cavity cancer 5 trials · 14 incl. sub-types Sub-types →
- Malignant cranial nerve neoplasm 0 trials · 4 incl. sub-types Sub-types →
- Cheek mucosa cancer 1 trial · 2 incl. sub-types Sub-types →
- Gingival cancer 1 trial · 2 incl. sub-types Sub-types →
- Malignant ear neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Malignant tumor of floor of mouth 0 trials · 2 incl. sub-types Sub-types →
- Hard palate cancer 0 trials · 1 incl. sub-types Sub-types →
- Angiosarcoma of the scalp 0 trials
- Malignant carotid body paraganglioma 0 trials
-
Nervous system cancer 17 trials · 1,997 incl. sub-types
6 sub-types
- Central nervous system cancer 130 trials · 1,700 incl. sub-types Sub-types →
- Sensory system cancer 0 trials · 232 incl. sub-types Sub-types →
- Cutaneous neuroendocrine carcinoma 78 trials
- Peripheral nervous system cancer 0 trials · 66 incl. sub-types Sub-types →
- Ectomesenchymoma 1 trial
- Adrenal gland neuroblastoma 0 trials Sub-types →
-
Musculoskeletal system cancer 2 trials · 1,968 incl. sub-types
11 sub-types
- Bone cancer 79 trials · 1,921 incl. sub-types Sub-types →
- Muscle cancer 0 trials · 72 incl. sub-types Sub-types →
- Gingival cancer 1 trial · 2 incl. sub-types Sub-types →
- Synovium cancer 1 trial · 2 incl. sub-types Sub-types →
- Ameloblastic carcinoma 0 trials
- Broad ligament malignant neoplasm 0 trials Sub-types →
- Cartilage cancer 0 trials
- Laryngeal cartilage cancer 0 trials
- Round ligament malignant neoplasm 0 trials
- Tonsillar pillar cancer 0 trials
- Uterine ligament cancer 0 trials Sub-types →
-
Malignant urinary system neoplasm 75 trials · 1,664 incl. sub-types
10 sub-types
- Kidney cancer 244 trials · 851 incl. sub-types Sub-types →
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Urinary bladder cancer 39 trials · 682 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Ureter cancer 27 trials · 34 incl. sub-types Sub-types →
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Multiple endocrine neoplasia type 2B 2 trials
- Malignant prostate phyllodes tumor 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
-
Secondary malignant neoplasm 27 trials · 1,289 incl. sub-types
2 sub-types
- Metastatic malignant neoplasm 748 trials · 1,264 incl. sub-types Sub-types →
- Secondary carcinoma 1 trial · 169 incl. sub-types Sub-types →
-
High grade malignant neoplasm 0 trials · 1,240 incl. sub-types
3 sub-types
- Malignant glioma 250 trials · 916 incl. sub-types Sub-types →
- In situ carcinoma 25 trials · 318 incl. sub-types Sub-types →
- Anaplastic meningioma 9 trials
-
Integumentary system cancer 0 trials · 1,084 incl. sub-types
7 sub-types
- Skin cancer 117 trials · 798 incl. sub-types Sub-types →
- Breast adenocarcinoma 36 trials · 278 incl. sub-types Sub-types →
- Atypical lobular breast hyperplasia 11 trials
- Dermatofibrosarcoma protuberans 11 trials Sub-types →
- Bartholin gland carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Breast diffuse large B-cell lymphoma 1 trial
- Nipple carcinoma 0 trials Sub-types →
-
Sarcoma 493 trials · 1,026 incl. sub-types
22 sub-types
- Soft tissue sarcoma 296 trials · 645 incl. sub-types Sub-types →
- Osteosarcoma 169 trials · 173 incl. sub-types Sub-types →
- Ewing sarcoma 124 trials · 125 incl. sub-types Sub-types →
- Bone sarcoma 41 trials · 108 incl. sub-types Sub-types →
- Dendritic cell sarcoma 0 trials · 53 incl. sub-types Sub-types →
- Chondrosarcoma 39 trials · 44 incl. sub-types Sub-types →
- Small cell sarcoma 0 trials · 37 incl. sub-types Sub-types →
- Myeloid sarcoma 27 trials Sub-types →
- Uterine corpus sarcoma 12 trials · 19 incl. sub-types Sub-types →
- Spindle cell sarcoma 6 trials · 13 incl. sub-types Sub-types →
- Endometrioid stromal sarcoma 2 trials Sub-types →
- Ectomesenchymoma 1 trial
- Giant cell tumor of soft tissue 1 trial
- Sarcomatosis 1 trial Sub-types →
- Colon sarcoma 0 trials Sub-types →
- Lymphangiosarcoma 0 trials Sub-types →
- Mast cell sarcoma 0 trials
- Orbit sarcoma 0 trials Sub-types →
- Rectum sarcoma 0 trials Sub-types →
- Reticulum cell sarcoma 0 trials
- Sarcoma G1 0 trials
- Sarcoma of cervix uteri 0 trials Sub-types →
-
Malignant soft tissue neoplasm 7 trials · 650 incl. sub-types
3 sub-types
- Soft tissue sarcoma 296 trials · 645 incl. sub-types Sub-types →
- Malignant central nervous system mesenchymal, non-meningothelial neoplasm 0 trials Sub-types →
- Mediastinal soft tissue cancer 0 trials Sub-types →
-
Childhood malignant neoplasm 239 trials · 598 incl. sub-types
30 sub-types
- Childhood leukemia 23 trials · 172 incl. sub-types Sub-types →
- Pediatric lymphoma 3 trials · 141 incl. sub-types Sub-types →
- Childhood brain stem neoplasm 3 trials · 95 incl. sub-types Sub-types →
- Pediatric hepatocellular carcinoma 36 trials
- Childhood malignant kidney neoplasm 0 trials · 30 incl. sub-types Sub-types →
- Pediatric high-grade glioma 14 trials · 16 incl. sub-types Sub-types →
- Childhood precursor T-lymphoblastic lymphoma/leukemia 0 trials · 13 incl. sub-types Sub-types →
- Pediatric osteosarcoma 8 trials Sub-types →
- Childhood central nervous system primitive neuroectodermal neoplasm 6 trials Sub-types →
- Pleuropulmonary blastoma 4 trials Sub-types →
- Malignant childhood germ cell neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Pediatric fibrosarcoma 0 trials · 2 incl. sub-types Sub-types →
- Pediatric intraocular retinoblastoma 2 trials
- Childhood choroid plexus carcinoma 1 trial
- Childhood malignant schwannoma 1 trial
- Childhood oligodendroglioma 1 trial
- Extrarenal rhabdoid tumor 1 trial
- Childhood botryoid rhabdomyosarcoma 0 trials Sub-types →
- Childhood cerebral astrocytoma 0 trials Sub-types →
- Childhood epithelioid sarcoma 0 trials
- Childhood malignant melanoma 0 trials Sub-types →
- Childhood malignant mesenchymoma 0 trials
- Childhood pleomorphic rhabdomyosarcoma 0 trials
- Pediatric angiosarcoma 0 trials
- Pediatric extraocular retinoblastoma 0 trials
- Pediatric infratentorial ependymoma 0 trials
- Pediatric liposarcoma 0 trials
- Pediatric mesenchymal chondrosarcoma 0 trials
- Pediatric myxoid chondrosarcoma 0 trials
- Pediatric supratentorial ependymoma 0 trials
-
Peritoneum cancer 67 trials · 513 incl. sub-types
6 sub-types
- Peritoneal carcinoma 16 trials · 389 incl. sub-types Sub-types →
- Peritoneal carcinomatosis 91 trials · 101 incl. sub-types Sub-types →
- Malignant peritoneal mesothelioma 13 trials
- Malignant peritoneal germ cell tumor 0 trials
- Malignant peritoneal solitary fibrous tumor 0 trials
- Round ligament malignant neoplasm 0 trials
-
Refractory malignant neoplasm 222 trials · 229 incl. sub-types
1 sub-type
- Testis refractory cancer 13 trials
-
Malignant mixed neoplasm 0 trials · 165 incl. sub-types
15 sub-types
- Carcinosarcoma 30 trials · 70 incl. sub-types Sub-types →
- Wilms tumor 60 trials · 63 incl. sub-types Sub-types →
- Uterine body mixed cancer 0 trials · 14 incl. sub-types Sub-types →
- Ovarian seromucinous carcinoma 13 trials
- Anaplastic oligoastrocytoma 12 trials
- Malignant phyllodes tumor 0 trials · 5 incl. sub-types Sub-types →
- Adenosarcoma 0 trials · 2 incl. sub-types Sub-types →
- Carcinoma ex pleomorphic adenoma 1 trial Sub-types →
- Combined lung carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Mixed lobular and ductal breast carcinoma 1 trial Sub-types →
- Adenoacanthoma 0 trials
- Adenocarcinofibroma 0 trials Sub-types →
- Gonadoblastoma 0 trials Sub-types →
- Malignant mixed epithelial stromal tumor of the kidney 0 trials
- Malignant vaginal mixed epithelial and mesenchymal neoplasm 0 trials Sub-types →
-
Anaplastic cancer 0 trials · 156 incl. sub-types
8 sub-types
- Anaplastic astrocytoma 53 trials · 99 incl. sub-types Sub-types →
- Anaplastic oligodendroglioma 22 trials · 35 incl. sub-types Sub-types →
- Sarcomatoid carcinoma 1 trial · 26 incl. sub-types Sub-types →
- Anaplastic ependymoma 7 trials · 12 incl. sub-types Sub-types →
- Anaplastic oligoastrocytoma 12 trials
- Primary cutaneous anaplastic large cell lymphoma 11 trials
- Anaplastic meningioma 9 trials
- Central nervous system anaplastic large cell lymphoma 0 trials
-
Cardiovascular cancer 0 trials · 153 incl. sub-types
2 sub-types
- Vascular cancer 1 trial · 150 incl. sub-types Sub-types →
- Heart cancer 2 trials · 4 incl. sub-types Sub-types →
-
Malignant mesothelioma 37 trials · 108 incl. sub-types
11 sub-types
- Malignant pleural mesothelioma 71 trials · 75 incl. sub-types Sub-types →
- Malignant peritoneal mesothelioma 13 trials
- Malignant epithelioid mesothelioma 5 trials · 12 incl. sub-types Sub-types →
- Malignant biphasic mesothelioma 2 trials · 5 incl. sub-types Sub-types →
- Diffused pleural mesothelioma 3 trials
- Sarcomatoid mesothelioma 2 trials · 3 incl. sub-types Sub-types →
- Localized pleural mesothelioma 2 trials
- Malignant pericardial mesothelioma 0 trials
- Mesothelioma of the tunica vaginalis 0 trials
- Ovarian malignant mesothelioma 0 trials
- Pleural mesothelioma in situ 0 trials
-
Lipomatous cancer 0 trials · 83 incl. sub-types
1 sub-type
- Liposarcoma 58 trials · 83 incl. sub-types Sub-types →
-
Retroperitoneal cancer 3 trials · 82 incl. sub-types
4 sub-types
- Adrenal gland cancer 16 trials · 62 incl. sub-types Sub-types →
- Retroperitoneum carcinoma 0 trials · 52 incl. sub-types Sub-types →
- Retroperitoneal sarcoma 17 trials Sub-types →
- Retroperitoneal lymphoma 0 trials
-
Malignant germ cell tumor 14 trials · 70 incl. sub-types
13 sub-types
- Malignant testicular germ cell tumor 14 trials · 36 incl. sub-types Sub-types →
- Extragonadal germ cell cancer 0 trials · 22 incl. sub-types Sub-types →
- Seminoma 22 trials Sub-types →
- Germinoma 7 trials · 9 incl. sub-types Sub-types →
- Mixed germ cell tumor 3 trials · 5 incl. sub-types Sub-types →
- Malignant germ cell tumor of ovary 2 trials · 4 incl. sub-types Sub-types →
- Malignant childhood germ cell neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Malignant teratoma 1 trial · 3 incl. sub-types Sub-types →
- Dysgerminoma 1 trial Sub-types →
- Malignant germ cell tumor of cervix uteri 0 trials
- Malignant germ cell tumor of corpus uteri 0 trials Sub-types →
- Pulmonary artery choriocarcinoma 0 trials
- Vaginal germ cell malignant tumor 0 trials Sub-types →
-
Cancer of unknown primary site 54 trials
-
Malignant spindle cell neoplasm 0 trials · 40 incl. sub-types
4 sub-types
- Sarcomatoid carcinoma 1 trial · 26 incl. sub-types Sub-types →
- Spindle cell sarcoma 6 trials · 13 incl. sub-types Sub-types →
- Desmoplastic melanoma 1 trial
- Spindle cell intraocular melanoma 0 trials Sub-types →
-
Blastoma 0 trials · 4 incl. sub-types
3 sub-types
- Pulmonary blastoma 1 trial · 4 incl. sub-types Sub-types →
- Gonadoblastoma 0 trials Sub-types →
- Pituitary blastoma 0 trials
-
Malignant giant cell tumor 0 trials · 4 incl. sub-types
4 sub-types
-
Malignant glomus tumor 1 trial
-
Malignant adenoma 0 trials
1 sub-type
- Malignant cystadenoma 0 trials
-
Malignant mesenchymoma 0 trials
2 sub-types
- Adult malignant mesenchymoma 0 trials
- Childhood malignant mesenchymoma 0 trials
Most studied deeper sub-types
-
New cancer drug GEN1057 tested in early trial – but study stopped early
Disease control Stopped earlyThis early-stage trial tested a new antibody drug called GEN1057 in 23 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and see how the drug behaves in the body. The study was terminated early, so results ar…
Phase 1 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New antibody combo shows promise in early cancer trial
Disease control Stopped earlyThis trial tests a new antibody called acasunlimab, alone or with other cancer drugs, in people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first to find safe doses, then to see how well those doses work. About 429 participa…
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Supercharged immune cells take on cancer in new trial
Disease control Stopped earlyThis study tests whether specially engineered immune cells (EIE) can safely fight cancer. Researchers take a patient's own immune cells, modify them to target tumor-related markers, and infuse them back. The trial involves 100 people with various cancers whose tumors show specifi…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Immune cells take on nerve tumors: new trial launches
Disease control Stopped earlyThis early-stage trial is testing whether specially engineered immune cells (called CAR-T and CTL cells) and a dendritic cell vaccine can safely treat people with neurofibromatosis or schwannomatosis, conditions that cause nerve tumors. The study will enroll 100 participants aged…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Engineered immune cells take aim at two cancer targets
Disease control Stopped earlyThis study tests a new treatment using a patient's own immune cells, engineered to recognize and attack cancer cells that have two specific markers (GD2 and CD56). The trial includes 60 people with advanced cancers that have not responded to standard therapy. The goal is to see i…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Engineered immune cells take aim at two cancer targets
Disease control Stopped earlyThis study tests a new treatment called bi-specific CAR-T cells that target two proteins, PSMA and CD70, found on some cancer cells. The therapy involves taking a patient's own immune cells, engineering them to recognize and attack these proteins, and infusing them back. The tria…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Experimental drug targets tough blood cancers in first human trial
Disease control Stopped earlyThis early-stage trial tested an experimental drug called SAR442257 in 47 adults with relapsed or refractory multiple myeloma or non-Hodgkin lymphoma. The main goals were to find a safe dose and check for side effects. Researchers also looked for signs that the drug might fight t…
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Engineered immune cells take on viruses in cancer patients
Disease control Stopped earlyThis early-stage trial is testing whether genetically modified T-cells can safely control viral infections in cancer patients with weakened immune systems. The T-cells are designed to target specific viruses like CMV, BK virus, or COVID-19. The study involves 30 participants and …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New antibody combo tackles solid tumors in early trial
Disease control Stopped earlyThis early-phase trial tested a new antibody drug, GEN1055, in 21 adults with advanced solid tumors. The goal was to check safety and find the right dose when used alone or with pembrolizumab (with or without chemotherapy). The study was stopped early, but results help guide futu…
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a protein calm the immune System's overreaction to cancer treatment?
Disease control Stopped earlyThis early-phase trial tests whether an experimental protein called CD24Fc can help people with advanced solid tumors recover from severe immune-related side effects caused by immunotherapy. These side effects occur when the immune system attacks healthy tissues. CD24Fc is design…
Phase 1/2 • Sponsor: Tianhong Li • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Experimental lung inflammation treatment trial shuts down after just one patient
Disease control Stopped earlyThis phase 2 trial aimed to see if infliximab and intravenous immunoglobulin (IVIG) could help cancer patients with severe lung inflammation that didn't respond to steroids. Only one patient was enrolled before the study was terminated, so no meaningful results were obtained. The…
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Electric field device takes on liver tumors in early trial
Disease control Stopped earlyThis early-phase study tests a portable device that sends gentle electric fields to the liver, combined with chemotherapy and a targeted drug (bevacizumab), in people whose cancer has spread to the liver and stopped responding to standard treatments. The main goal is to find the …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a new nucleotide analogue boost cancer treatment?
Disease control Stopped earlyThis trial is testing an experimental drug called NUC-3373, a nucleotide analogue, in combination with standard cancer drugs for people with advanced solid tumors. The study has two parts: one combining NUC-3373 with pembrolizumab, and the other combining it with docetaxel. The g…
Phase 1/2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control Stopped earlyThis early-stage trial tests the safety and best dose of the drug neratinib when combined with one of three other drugs (everolimus, palbociclib, or trametinib) in people with advanced solid tumors that have certain gene mutations or amplifications. The study enrolls 93 participa…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New cancer drug candidate enters early human testing
Disease control Stopped earlyThis early-phase trial is testing a new oral drug called zamzetoclax (GS-9716) in about 145 people with advanced solid tumors. The drug is given alone or combined with standard chemotherapies. The main goals are to find the safest dose and understand side effects. This is a safet…
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug OB318 enters human testing for Hard-to-Treat cancers
Disease control Stopped earlyThis Phase 1 trial tests an experimental drug called OB318 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and to understand how the body processes the drug. Researchers will also look for early signs tha…
Phase 1 • Sponsor: Oneness Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Spine cancer combo therapy trial ends early after just one patient
Disease control Stopped earlyThis early-stage study tested combining targeted spine radiation with the immunotherapy drug pembrolizumab in people with advanced spinal tumors pressing on the spinal cord. Only one person enrolled before the study was stopped early. The goal was to see if this treatment approac…
Early phase 1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New cancer drug combo tested in tiny trial – but halted early
Disease control Stopped earlyThis early-stage trial tested an experimental drug called BND-35, alone or combined with nivolumab or cetuximab, in 12 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. The study was te…
Phase 1 • Sponsor: Biond Biologics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Promising combo for AML after transplant falls short as trial ends early
Disease control Stopped earlyThis study tested whether adding venetoclax and azacitidine after a stem cell transplant could help people with acute myeloid leukemia (AML) live longer. It included adults and teens who had recently received a transplant. The trial was stopped early, so the full benefits and ris…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Lung cancer drug trial halted early: what happened?
Disease control Stopped earlyThis study tested an experimental drug called cofetuzumab pelidotin for people with a specific type of advanced lung cancer (non-small cell lung cancer) that had returned after other treatments. The drug was designed to target a protein called PTK7 found on cancer cells. The stud…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New cocktail of cancer drugs tested in desperate cases
Disease control Stopped earlyThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immune cell rescue after radiation shows promise in early cancer trial
Disease control Stopped earlyThis study tested whether giving patients their own immune cells (called lymphocytes) after chemotherapy and radiation could help their immune system recover faster. It included 19 adults with lung or esophageal cancer. The treatment was designed to reduce a common side effect of…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New cancer drug trial halted early: what we know
Disease control Stopped earlyThis early-stage study tested a new drug called NM6603 in 17 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find the safest dose and check for side effects. The trial was ended early, so results are limited.
Phase 1 • Sponsor: NucMito Pharmaceuticals Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Experimental triple therapy for advanced cancers shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested the drug plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combination was safe and could shrink…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Tailored cancer therapy put to the test
Disease control Stopped earlyThis study tested a precision medicine approach for people with advanced cancers like breast, ovarian, pancreatic, prostate, or sarcoma. Researchers used genetic and protein tests to track how the cancer changes and then a team of experts recommended personalized drugs. The goal …
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Experimental cancer drug AUR106 tested in humans for first time
Disease control Stopped earlyThis early-stage trial tested an experimental drug called AUR106 in 21 adults with advanced solid tumors (lung, stomach, bladder, kidney, colon, or esophageal cancer) that had come back or spread. The main goals were to check safety, find the right dose, and see how the drug move…
Phase 1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Experimental combo shot for pancreatic cancer stalls after just 2 patients
Disease control Stopped earlyThis very early trial tested two immune-stimulating drugs injected directly into tumors for people with stage IV pancreatic cancer. The goal was to see if the combination could shrink tumors or slow their growth. However, the study was stopped early after enrolling only 2 partici…
Phase 1/2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Cancer Patients' chest fluid: can a Clot-Buster help drain it?
Disease control Stopped earlyThis study tested whether a drug called TNK (tenecteplase) could help drain loculated (pocketed) fluid from the chest in cancer patients better than a saltwater solution. The trial planned to enroll about 20 adults with cancer and a chest tube already in place. However, the study…
Phase 2/3 • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Experimental combo targets tough tumors
Disease control Stopped earlyThis early-stage study tested a new drug combination (MGN1703 plus ipilimumab) in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find the safest dose of MGN1703 when given with ipilimumab. The study was stopped early, bu…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Experimental INKmune therapy for blood cancers halted after just 2 patients
Disease control Stopped earlyThis early-stage study tested an experimental drug called INKmune in people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The goal was to find a safe dose and check for side effects. However, the study was stopped early after only 2 people enrolled, so no c…
Phase 1 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Immune cell therapy tested for tough childhood cancers
Disease control Stopped earlyThis early-phase study tested a treatment using donated natural killer (NK) cells from cord blood, combined with chemotherapy, for children and young adults with solid tumors that returned or didn't respond to standard care. The goal was to find the safest dose and check for side…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Experimental cancer drug DS-9606a tested in early trial, but stopped early
Disease control Stopped earlyThis early-phase study tested an experimental drug called DS-9606a in 88 people with advanced solid tumors that have a specific protein (Claudin-6). The main goal was to check safety and find the right dose. The trial was terminated, meaning it stopped before completion, so we ha…
Phase 1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Experimental cancer drug BR105 trial stopped early
Disease control Stopped earlyThis early-phase study tested an experimental drug called BR105 in 31 adults with advanced cancers that no longer responded to standard treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink tumors. The trial was stopped early, so r…
Phase 1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Experimental cancer drug trial halted early
Disease control Stopped earlyThis early-stage study tested a new antibody drug (BGB-B3227) alone or with another drug (tislelizumab) in 35 people with advanced solid tumors. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Phase 1 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Tailored cancer cocktail tested for tough childhood tumor
Disease control Stopped earlyThis trial tested a personalized approach for children with relapsed or hard-to-treat neuroblastoma. Doctors used a tumor biopsy to find genetic changes and then assigned a combination of targeted drugs (ceritinib and ribociclib) to match those changes. The study was terminated e…
Phase 1 • Sponsor: Yael P Mosse • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Promising cancer combo trial halted early
Disease control Stopped earlyThis study tested a new drug (BMS-986218) plus nivolumab and targeted radiation in people with advanced solid tumors that had spread. The goal was to see if this combination could help the immune system fight cancer better. Only 13 people took part before the study was stopped ea…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Quit smoking before surgery to cut complications, study finds
Disease control Stopped earlyThis study looked at whether a structured smoking cessation program starting four weeks before surgery could reduce complications in smokers undergoing intermediate to high-risk operations. Researchers planned to enroll 251 adult smokers scheduled for surgeries like abdominal, th…
Sponsor: Luzerner Kantonsspital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Experimental cancer drug GEN1078 tested in just 3 people – trial halted early
Disease control Stopped earlyThis early-phase trial tested an experimental drug called GEN1078 in 3 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check for side effects and see how the body processes the drug. The trial was terminated early, so r…
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New cancer drug tested in people with advanced tumors
Disease control Stopped earlyThis early study tested a new drug called PHN-010 in 26 people with advanced cancers like lung, colon, and ovarian cancer. The drug is designed to deliver a powerful treatment directly to cancer cells. The main goals were to check safety and find the right dose, but the study was…
Phase 1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
HIV cancer hope: immune combo shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested two immunotherapy drugs, ipilimumab and nivolumab, in people with HIV who had advanced solid tumors or Hodgkin lymphoma that had spread or come back. The goal was to find the safest dose and see if the combination could shrink tumors. The study was t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New cancer drug OC-001 tested in advanced tumors – trial ends early
Disease control Stopped earlyThis early-phase trial tested an experimental drug called OC-001, given alone or with the immunotherapy avelumab, in 73 people with various advanced or metastatic cancers (like lung, breast, and bladder cancer). The main goals were to check safety and how the drug moves through t…
Phase 1/2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Cancer Patients' COVID-19 trial halted after just 4 volunteers
Disease control Stopped earlyThis early-phase study aimed to see if combining two immune-stimulating drugs (rintatolimod and interferon alpha-2b) could help cancer patients fight off COVID-19. Only 4 people took part before the study was stopped early. The main goals were to check safety and measure how the …
Phase 1/2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Promising breast cancer drug trial halted early
Disease control Stopped earlyThis study tested a new drug called PLX038 in 14 people with advanced triple-negative breast cancer that had already been treated. The goal was to see if the drug could shrink tumors. The trial was stopped early, so results are limited.
Phase 2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Experimental cancer drug study halted early
Disease control Stopped earlyThis study tested an experimental drug called SQ3370 in 53 people with advanced solid tumors that had spread or could not be removed by surgery. The goal was to check the drug's safety and find the best dose, as well as see if it could shrink tumors. The study was terminated earl…
Phase 1/2 • Sponsor: Shasqi, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Targeted drug pemigatinib tested in tumors with FGFR mutations – trial stopped early
Disease control Stopped earlyThis phase 2 study tested the drug pemigatinib in 111 people with advanced solid tumors that have specific FGFR gene mutations or translocations. The goal was to see if the drug could shrink tumors. The trial was terminated early, so the full results are not available.
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for brain metastases? study tests pembrolizumab combo
Disease control Stopped earlyThis study looked at whether adding the drug pembrolizumab to chemotherapy could help people with a type of lung cancer that has spread to the brain but isn't causing symptoms. The goal was to control the cancer in the brain and body while keeping quality of life. Only 3 people t…
Phase 2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Cancer cocktail trial halted early – what went wrong?
Disease control Stopped earlyThis study tested a combination of three drugs (azacitidine, pembrolizumab, and epacadostat) in 70 people with advanced solid tumors, including lung and colorectal cancers. The goal was to see if the combination was safe and could shrink tumors. However, the trial was terminated …
Phase 1/2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Early trial of experimental cancer drug halted; data still under review
Disease control Stopped earlyThis early-phase study tested a new drug called PF-07284890, alone or with another drug (binimetinib), in 65 people with advanced cancers that have a specific genetic change (BRAF V600 mutation), including cancers that spread to the brain. The trial was terminated early, but rese…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug combo tested for tough cancers
Disease control Stopped earlyThis early-stage study tested a new drug called ZL-1218, alone or with another cancer drug, in 34 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, side effects, and how the drug moves through the body. The …
Phase 1 • Sponsor: Zai Lab (Hong Kong), Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Immunotherapy combo shows promise for rare cancers, but study halted early
Disease control Stopped earlyThis phase 2 trial tested a combination of two immunotherapy drugs, durvalumab and tremelimumab, in 92 people with advanced rare solid tumors who had no other standard treatment options. The goal was to see if the drugs could shrink tumors and to check for side effects. The study…
Phase 2 • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Cancer combo trial halted early: what went wrong?
Disease control Stopped earlyThis early-phase study tested an experimental drug called BMS-986258, alone or combined with the immunotherapy nivolumab (Opdivo), in 92 people with advanced solid tumors like lung, kidney, or breast cancer. The main goal was to check safety and find the right dose. However, the …
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 26, 2026 17:56 UTC
-
Experimental HER2 drug trial halted early – what it means
Disease control Stopped earlyThis early-stage trial tested an experimental drug called SAR443216 in 44 adults with advanced HER2-expressing solid tumors (such as breast, lung, or gastric cancer) that had come back or stopped responding to standard treatments. The study aimed to find a safe dose and check for…
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 17:22 UTC
-
Personalized cancer vaccine trial halted early – what we know
Disease control Stopped earlyThis phase 2 trial tested a personalized cancer vaccine called TLPO in 63 people with various solid tumors. The vaccine was made from a patient's own tumor material to train their immune system to fight the cancer. The study aimed to see if the vaccine could delay disease progres…
Phase 2 • Sponsor: Elios Therapeutics, LLC • Aim: Disease control
Last updated Jun 26, 2026 16:56 UTC
-
Can a smartphone app help cancer survivors kick the habit?
Disease control Stopped earlyThis study tested whether a smartphone app (Craving-to-Quit) or group mindfulness sessions work better for helping cancer survivors stop smoking. Participants also used nicotine patches. The trial was terminated early and only enrolled 20 people, so the results are not conclusive…
Phase 4 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 26, 2026 15:23 UTC
-
A simple blood test may spot hidden infections in kids with cancer
Diagnosis Stopped earlyThis pilot study asks whether a blood marker called procalcitonin can help predict bacteremia—a serious bacterial infection in the blood—in children with cancer who develop a fever. Currently, doctors rely on blood cultures, which can take up to 48 hours or give false negatives. …
Sponsor: CAMC Health System • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
Can a simple test spot heart damage in cancer survivors?
Diagnosis Stopped earlyThis study looks at whether a special ECG and a blood test can find early signs of heart weakness in adult cancer survivors who had certain chemotherapy. Researchers will check how well these tests work compared to standard heart imaging. The goal is to gather information needed …
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
New PET tracer aims to light up tumors, but trial stalls
Diagnosis Stopped earlyThis early-phase trial tested a radioactive imaging agent called 68GaNOTA-Anti-MMR-VHH2 to see if it could safely highlight tumors on PET scans. It involved 13 adults with advanced solid tumors, breast cancer, or melanoma. The study was terminated early, so we have limited inform…
Phase 1/2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
New PET tracer aims to reveal hidden immune activity in tumors and arteries
Diagnosis Stopped earlyThis Phase II study tested a radioactive tracer called 68GaNOTA-Anti-MMR-VHH2 to see if it can light up certain immune cells (macrophages) on PET scans. The trial included 29 people with head and neck cancer, lymphoma, atherosclerosis, or sarcoidosis. The goal was to see if the t…
Phase 2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New scanner aims to spot tiny tumors, but study stalls early
Diagnosis Stopped earlyThis study tested a new imaging technique called AWSM-PET/CT that adds a few minutes to a standard PET/CT scan to get clearer pictures of small cancer spots. Researchers planned to enroll cancer patients to see if the new method improved accuracy. However, the study was stopped e…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Can a PET scan spot silent heart danger from cancer drugs?
Diagnosis Stopped earlyThis pilot study tested whether a special PET scan (FDG-PET/CT) can detect hidden heart inflammation in cancer patients receiving immune checkpoint inhibitors (ICIs). The goal was to catch this inflammation early, before it becomes severe. Only 2 participants were enrolled, and t…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
New imaging tool could help surgeons spot invisible oral cancers
Diagnosis Stopped earlyThis study tested whether a special imaging technique called narrow band imaging (NBI) can help surgeons find early cancer spots in the mouth that are not visible under normal light. The trial involved 23 people with oral cancer who were already scheduled for surgery. Doctors com…
Phase 2 • Sponsor: Centre Oscar Lambret • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Steroid-Free nausea control: new hope for chemo patients?
Symptom relief Stopped earlyThis study compared two standard drugs—olanzapine and dexamethasone—for preventing nausea and vomiting caused by chemotherapy. Researchers wanted to see if olanzapine could work as well as the steroid dexamethasone, potentially allowing patients to avoid steroid side effects. The…
Phase 4 • Sponsor: The Guthrie Clinic • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Fasting diet may ease immunotherapy side effects in cancer patients
Symptom relief Stopped earlyThis study tests whether a special low-calorie, plant-based diet that mimics fasting can reduce common side effects like rash, diarrhea, and fatigue in cancer patients receiving immunotherapy. Ten adults with advanced cancer will follow the diet and report their symptoms. The goa…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Can looking back help cancer patients and caregivers feel better?
Symptom relief Stopped earlyThis study tests a program where older adults with advanced cancer and their caregivers talk about their lives together. The goal is to see if this approach is practical and helps improve emotional well-being and relationship quality. About 60 patient-caregiver pairs will be rand…
Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a smartphone app help cancer patients fight depression?
Symptom relief Stopped earlyThis study tested whether a digital platform could improve collaborative care for depression in cancer patients. About 300 adults receiving cancer treatment with significant depression symptoms were enrolled. The platform aimed to help care managers track symptoms and coordinate …
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Morphine gel may offer direct relief for chemo mouth sores
Symptom relief Stopped earlyThis study tested a morphine gel applied directly to painful mouth sores caused by chemotherapy. The goal was to see if the gel could relieve pain better than morphine given through an IV. The study included children and young adults aged 5 to 25. The gel was applied four times a…
Phase 3 • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Exercise and diet tested for chemo nerve damage – but study halted early
Symptom relief Stopped earlyThis study tested whether a 12-week program of walking and resistance exercises or nutrition education could reduce nerve pain caused by platinum chemotherapy. The trial enrolled 36 adults with cancer who were receiving oxaliplatin or cisplatin. The study was terminated early, so…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
New program aims to help parents with advanced cancer support their kids
Symptom relief Stopped earlyThis study tested two educational programs for parents with late-stage cancer who have children aged 5 to 17. The programs were designed to improve parent-child relationships and boost parents' confidence in talking about cancer with their kids. Researchers hoped to reduce anxiet…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Can a smartphone app ease cancer treatment side effects?
Symptom relief Stopped earlyThis study tested whether a digital health app (Roche DPM Module) helps cancer patients manage symptoms and reduce healthcare visits while on systemic treatment. About 49 participants used the app alongside standard care. The trial was terminated early, so results are limited.
Phase 2/3 • Sponsor: Hoffmann-La Roche • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Virtual group aims to boost resilience in young cancer survivors facing dual health threats
Symptom relief Stopped earlyThis study tested an online support group for young adults (ages 18-39) who had cancer treatment and were feeling anxious or distressed during the COVID-19 pandemic. The goal was to see if teaching healthy coping skills through a virtual group could improve their mood and confide…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can bringing palliative care home ease suffering?
Symptom relief Stopped earlyThis study tested whether providing palliative care at home, through a team of doctors, nurses, social workers, and chaplains, could improve symptoms and quality of life for people with advanced cancer, heart failure, or COPD. The plan was to enroll over 1,100 patients, but the t…
Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Cancer rash drug trial halted early – little known
Symptom relief Stopped earlyThis small, early-stage trial tested a drug called imsidolimab for treating acne-like skin rashes that can occur in cancer patients taking certain targeted therapies. Only 4 people were enrolled before the study was stopped. Because of the very small size and early termination, w…
Phase 2 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Could a genetic marker guide future cancer therapies in taiwan?
Knowledge-focused Stopped earlyThis study is measuring how often a specific genetic marker (HLA-A*02:01) and a cancer-related protein (NY-ESO-1) appear in Taiwanese patients with solid tumors like head and neck, liver, lung, breast, and esophageal cancers. By understanding these frequencies, researchers hope t…
Sponsor: PharmaEssentia • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New app aims to improve cancer care for seniors
Knowledge-focused Stopped earlyThis study tested an electronic platform called eGAP that helps older cancer patients (65+) complete questionnaires about their health. The goal was to see if the platform was easy to use and practical for patients, caregivers, and doctors. The study was terminated early after en…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
COVID-19 vaccine safety checked in cancer immunotherapy patients
Knowledge-focused Stopped earlyThis study aimed to see if COVID-19 vaccines cause more side effects in cancer patients receiving immunotherapy. Researchers planned to track 125 patients from several hospitals in France, recording any local or systemic side effects. The study was terminated early, so the full r…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New platform seeks to break down barriers for underserved cancer patients in clinical trials
Knowledge-focused Stopped earlyThis study looked at why minority cancer patients often don't take part in clinical trials. Researchers surveyed patients about their understanding and attitudes, then tested an educational video and booklet to see if it boosted enrollment. The goal was to create a personalized p…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Can pictures help patients understand research better?
Knowledge-focused Stopped earlyThis study tested whether a visual consent form with pictures helps patients with cancer or Alzheimer's understand research better than standard text. Researchers planned to enroll 266 adults across three U.S. sites. The trial was terminated early, so results may be limited.
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Fitness trackers vs. Doctor's eye: which better gauges cancer Patients' mobility?
Knowledge-focused Stopped earlyThis study tested whether consumer movement trackers could provide a more precise measure of cancer patients' physical abilities than the standard ECOG score, which relies on a doctor's observation. Researchers enrolled 41 cancer patients and used a Kinect device to record their …
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Nano-X rotation study for cancer patients ends early
Knowledge-focused Stopped earlyThis study looked at how cancer patients experience being rotated horizontally in the Nano-X system. 43 patients completed questionnaires about anxiety and motion sickness before and after rotation. The study was terminated early, so findings are limited.
Sponsor: University of Sydney • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Cancer genetic Pre-Screening study halted after just 8 patients
Knowledge-focused Stopped earlyThis study aimed to screen cancer patients for genetic markers before they joined other clinical trials, hoping to save time and improve drug dosing. Only 8 adults were enrolled before the study was terminated early. The approach was meant to help match patients to the right tria…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Liver impairment study for cancer drug tazemetostat halted early
Knowledge-focused Stopped earlyThis study looked at how the cancer drug tazemetostat is processed in the body of people with advanced solid tumors who also have moderate or severe liver impairment. Researchers compared drug levels in these patients to those with normal liver function. The trial was terminated …
Phase 1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Tiny study on brown fat and cancer metabolism halted early
Knowledge-focused Stopped earlyThis pilot study aimed to understand how brown adipose tissue (brown fat) might contribute to weight loss in cancer patients. Researchers planned to measure energy use in patients with and without active brown fat. However, the study was terminated early and only enrolled 3 parti…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Scientists test a 'non-stick' patch from body cells to stop surgical scars
Knowledge-focused Stopped earlyThis lab study tested two types of human cells to see which could best form a non-stick patch to prevent internal scar tissue after cancer surgery. Researchers collected cells from the peritoneum (lining of the abdomen) and from fat tissue, then grew them in the lab. The study wa…
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Scientists tap cancer fluids for clues to better treatments
Knowledge-focused Stopped earlyThis study collected fluid from the abdomen or lungs, plus blood, from 22 adults with solid tumors. The goal was to learn more about cancer biology, not to provide a direct treatment. Researchers hope these samples will help them understand how cancer grows and lead to better the…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Pregnancy pollution link? new study probes environmental cancer risks
Knowledge-focused Stopped earlyThe DREAM study is an observational research project that enrolled over 1,500 pregnant women and their children to understand how exposure to environmental chemicals—like those in consumer products, air, and water—might influence cancer risk. Researchers collected blood, urine, a…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Cancer Patients' COVID risk explored in terminated study
Knowledge-focused Stopped earlyThis study aimed to understand how COVID-19 affects people with cancer, especially those receiving treatment. Researchers planned to measure how many cancer patients had COVID-19 without symptoms and how their immune systems responded. The study was terminated early, so results a…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Registry launched to understand young adult cancer Survivors' wellbeing
Knowledge-focused Stopped earlyThis observational registry aims to learn about the health, wellbeing, and needs of people who were diagnosed with cancer between ages 18 and 39. Participants complete surveys every 6 to 12 months about anxiety, depression, social support, and financial distress. The registry als…
Sponsor: Young Adult Survivors United • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Brain surgery scanner tested – but study halted early
Knowledge-focused Stopped earlyThis study tested a new 3D scanner to measure how the brain shifts during surgery for epilepsy or tumor removal. Only one person took part before the study was stopped. The goal was to see if the scanner could accurately track brain surface changes over time, which could help sur…
Sponsor: Advanced Scanners Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Fitbits could predict cancer trial side effects
Knowledge-focused Stopped earlyThis study tested whether wearable fitness trackers (like Fitbits) and smartphone diaries can give a more accurate picture of cancer patients' physical function than standard doctor assessments. Researchers enrolled 31 cancer patients starting early-phase clinical trials. The goa…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:54 UTC